News
MSD, known as Merck in the US and Canada, has received approval from the European Commission (EC) for its anti-PD-1 therapy KEYTRUDA, as a...
The FDA has approved Aurinia Pharmaceuticals’ LUPKYNIS (voclosporin) in combination with a background immunosuppressive therapy regimen to treat...
AstraZeneca has rejected claims by German media that its COVID-19 vaccine has only 8% efficacy in over-65s.
Merck, known as MSD outside of the US and Canada, has announced that the company is discontinuing development of its COVID-19 vaccine candidates,...
The European Commission (EC) has approved AbbVie’s RINVOQTM (upadacitinib 15 mg), an oral, once-daily selective and reversible JAK inhibitor for...
NovAliX, a drug discovery-focused contract research organisation, and Chemical.AI, an artificial intelligence (AI) company, have announced a...
The FDA has approved Exelixis’ Cabometyx (cabozantinib) for patients with advanced renal cell carcinoma (RCC) as a first-line treatment in...
Digital health platform Curelator has announced new data that shows a lack of association between increased stress and migraine attacks.
Genentech has announced positive top-line results from two identically designed global Phase III studies, TENAYA and LUCERNE, evaluating its...
The EC has approved Merck KGaA’s BAVENCIO (avelumab) as monotherapy for the first-line maintenance treatment of adult patients with locally...